Molecular Basis of Buspirone's Anxiolytic Action
- 1 September 1991
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 69 (3), 149-156
- https://doi.org/10.1111/j.1600-0773.1991.tb01289.x
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Quantitative autoradiographic distribution and pharmacological characterization of (3H)buspirone binding to sections from rat, bovine and marmoset brainJournal of Neural Transmission, 1989
- Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspironeBritish Journal of Pharmacology, 1989
- Novel anxiolytics discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampusNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1987
- Neuroendocrine effects of buspirone in patients with generalized anxiety disorderAmerican Journal Of Medicine, 1986
- 1-(2-Pyrimidinyl)-Piperazine as Active Metabolite of Buspirone in Man and RatPharmacology, 1986
- Monoaminergic involvement in the pharmacological actions of buspironeBritish Journal of Pharmacology, 1985
- The Effect of Buspirone on Prolactin and Growth Hormone Secretion in ManArchives of General Psychiatry, 1983
- The comparative efficacy of buspirone and diazepam in the treatment of anxietyAmerican Journal of Psychiatry, 1979
- Antianxiety Drugs: Clinical use in PsychiatryPublished by Springer Nature ,1978
- Effect of diazepam on plasma corticosterone levels in the ratJournal of Pharmacy and Pharmacology, 1969